Exercise or conversion by James Young of 4600 shares of Novavax subject to Rule 16b-3
SNCEDelisted Stock | USD 0.28 0.02 7.69% |
About 55% of Science 37's shareholders are presently thinking to get in. The analysis of current outlook of investing in Science 37 Holdings suggests that some traders are interested regarding Science 37's prospects. The current market sentiment, together with Science 37's historical and current headlines, can help investors time the market. In addition, many technical investors use Science 37 Holdings stock news signals to limit their universe of possible portfolio assets.
Science |
Filed transaction by Novavax Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
Read at macroaxis.com
Science 37 Fundamental Analysis
We analyze Science 37's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Science 37 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Science 37 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Science 37 is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Science 37 Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Science 37 stock to make a market-neutral strategy. Peer analysis of Science 37 could also be used in its relative valuation, which is a method of valuing Science 37 by comparing valuation metrics with similar companies.
Peers
Science 37 Related Equities
NUTX | Nutex Health | 5.49 | ||||
MGRX | Mangoceuticals, Common | 2.02 | ||||
FORA | Forian | 1.94 | ||||
BEAT | Heartbeam | 1.79 | ||||
HSTM | HealthStream | 1.51 | ||||
NRC | National Research | 0.31 | ||||
EUDA | EUDA Health | 1.59 | ||||
FOXO | FOXO Technologies | 3.45 | ||||
HCTI | Healthcare Triangle | 18.07 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Science Stock
If you are still planning to invest in Science 37 Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Science 37's history and understand the potential risks before investing.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |